MedPacto, Inc. (KOSDAQ:235980)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,565.00
+515.00 (16.89%)
Nov 2, 2026, 3:30 PM KST

MedPacto Revenue

MedPacto had revenue of 1.05B KRW in the quarter ending June 30, 2026, with 24.97% growth. This brings the company's total for the last twelve months to 4.99B, up 293.41% year-over-year. In the year 2025, MedPacto had annual revenue of 3.90B. That makes MedPacto the 40,882nd largest company in the world by revenue and 2,523rd in South Korea.

Revenue (ttm)
4.99B
Revenue Growth
+293.41%
P/S Ratio
20.93
Revenue / Employee
89.19M
Employees
56
Market Cap
122.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.90B--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bioneer345.88B
GC Cell162.00B
Amicogen46.69B
GC Genome32.64B
Anterogen.Co.,Ltd.8.37B
Genexine5.81B
iNtRON Biotechnology5.74B
Genomictree2.95B
Revenue Rankings